Literature DB >> 20087186

Genetics of bronchopulmonary dysplasia in the age of genomics.

Pascal M Lavoie1, Marie-Pierre Dubé.   

Abstract

PURPOSE OF REVIEW: According to recent evidence, susceptibility to bronchopulmonary dysplasia (BPD) in preterm infants is predominantly inherited. The purpose of this review is to discuss current published genetic association studies in light of the accumulated knowledge in genomics. RECENT
FINDINGS: Major advances in the development of next-generation genotyping and sequencing platforms, statistical methodologies, inventories of functional outcome of some common genetic polymorphisms and large-scale cataloguing of genetic variability among many of the world's ethnic populations have greatly facilitated the study of polygenic conditions. For BPD, genetic-association studies have primarily focused on components of innate (e.g. first-line) immune and antioxidant defences, mechanisms of vascular and lung remodelling, and surfactant proteins. However, studies have been limited in sample size and therefore fraught with a high probability of false-positive and false-negative associations. Nonetheless, candidate gene associations have indicated some novel biological pathways and provide a conceptual framework for the design of larger, collaborative population-based studies.
SUMMARY: Although studies to date have not been able to identify reproducible genetic risk markers for BPD, they have directed us towards new, promising research avenues.

Entities:  

Mesh:

Year:  2010        PMID: 20087186      PMCID: PMC5104534          DOI: 10.1097/MOP.0b013e328336eb85

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  55 in total

1.  Principal components analysis corrects for stratification in genome-wide association studies.

Authors:  Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

2.  Potential etiologic and functional implications of genome-wide association loci for human diseases and traits.

Authors:  Lucia A Hindorff; Praveen Sethupathy; Heather A Junkins; Erin M Ramos; Jayashri P Mehta; Francis S Collins; Teri A Manolio
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-27       Impact factor: 11.205

Review 3.  The TDT and other family-based tests for linkage disequilibrium and association.

Authors:  R S Spielman; W J Ewens
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

4.  Deletion allele of angiotensin-converting enzyme is associated with increased risk and severity of bronchopulmonary dysplasia.

Authors:  S Nadya J Kazzi; Michael W Quasney
Journal:  J Pediatr       Date:  2005-12       Impact factor: 4.406

5.  Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization.

Authors:  Bernard Thébaud; Faruqa Ladha; Evangelos D Michelakis; Monika Sawicka; Gavin Thurston; Farah Eaton; Kyoko Hashimoto; Gwyneth Harry; Alois Haromy; Greg Korbutt; Stephen L Archer
Journal:  Circulation       Date:  2005-10-18       Impact factor: 29.690

6.  Lack of association between FXIII-Val34Leu, FVII-323 del/ins, and transforming growth factor beta1 (915G/T) gene polymorphisms and bronchopulmonary dysplasia: a single-center study.

Authors:  Fatma Belgin Ataç; Deniz Anuk Ince; Hasibe Verdi; Zeynel Gökmen; Ayse Canan Yazici; Hande Gülcan; Aylin Tarcan; Ayse Taneri; Ezgi Sezgin; Namik Ozbek
Journal:  DNA Cell Biol       Date:  2010-01       Impact factor: 3.311

7.  Is chronic lung disease in low birth weight infants preventable? A survey of eight centers.

Authors:  M E Avery; W H Tooley; J B Keller; S S Hurd; M H Bryan; R B Cotton; M F Epstein; P M Fitzhardinge; C B Hansen; T N Hansen
Journal:  Pediatrics       Date:  1987-01       Impact factor: 7.124

8.  Polymorphism of tumor necrosis factor-alpha and risk and severity of bronchopulmonary dysplasia among very low birth weight infants.

Authors:  S Nadya J Kazzi; U Olivia Kim; Michael W Quasney; Irina Buhimschi
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

9.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

Authors:  A G Wilson; J A Symons; T L McDowell; H O McDevitt; G W Duff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

10.  The Human Gene Mutation Database: 2008 update.

Authors:  Peter D Stenson; Matthew Mort; Edward V Ball; Katy Howells; Andrew D Phillips; Nick St Thomas; David N Cooper
Journal:  Genome Med       Date:  2009-01-22       Impact factor: 11.117

View more
  19 in total

1.  Identification of SPOCK2 as a susceptibility gene for bronchopulmonary dysplasia.

Authors:  Alice Hadchouel; Xavier Durrmeyer; Emmanuelle Bouzigon; Roberto Incitti; Johanna Huusko; Pierre-Henri Jarreau; Richard Lenclen; Florence Demenais; Marie-Laure Franco-Montoya; Inès Layouni; Juliana Patkai; Jacques Bourbon; Mikko Hallman; Claude Danan; Christophe Delacourt
Journal:  Am J Respir Crit Care Med       Date:  2011-08-11       Impact factor: 21.405

2.  A genome-wide association study (GWAS) for bronchopulmonary dysplasia.

Authors:  Hui Wang; Krystal R St Julien; David K Stevenson; Thomas J Hoffmann; John S Witte; Laura C Lazzeroni; Mark A Krasnow; Cecele C Quaintance; John W Oehlert; Laura L Jelliffe-Pawlowski; Jeffrey B Gould; Gary M Shaw; Hugh M O'Brodovich
Journal:  Pediatrics       Date:  2013-07-29       Impact factor: 7.124

3.  Association of vitamin D binding protein polymorphisms with bronchopulmonary dysplasia: a case-control study of gc globulin and bronchopulmonary dysplasia.

Authors:  O Serce Pehlevan; G Karatekin; V Koksal; D Benzer; T Gursoy; T Yavuz; F Ovali
Journal:  J Perinatol       Date:  2015-06-11       Impact factor: 2.521

4.  A 24-year-old woman with episodes of shortness of breath, cough and wheezing.

Authors:  Vivek Dhawan; Meena Kalluri
Journal:  CMAJ       Date:  2013-04-08       Impact factor: 8.262

Review 5.  Targeting inflammation to prevent bronchopulmonary dysplasia: can new insights be translated into therapies?

Authors:  Clyde J Wright; Haresh Kirpalani
Journal:  Pediatrics       Date:  2011-06-06       Impact factor: 7.124

Review 6.  Perinatal inflammation and lung injury.

Authors:  Rose Marie Viscardi
Journal:  Semin Fetal Neonatal Med       Date:  2011-09-08       Impact factor: 3.926

7.  Recurrent copy number variants associated with bronchopulmonary dysplasia.

Authors:  Ausaf Ahmad; Soumyaroop Bhattacharya; Arthi Sridhar; Anwar M Iqbal; Thomas J Mariani
Journal:  Pediatr Res       Date:  2016-03-14       Impact factor: 3.756

8.  Toll-like receptor genetic variants are associated with Gram-negative infections in VLBW infants.

Authors:  V Sampath; N P Mulrooney; J S Garland; J He; A L Patel; J D Cohen; P M Simpson; R N Hines
Journal:  J Perinatol       Date:  2013-07-18       Impact factor: 2.521

9.  Hydrogen sulfide, oxygen, and calcium regulation in developing human airway smooth muscle.

Authors:  Colleen M Bartman; Marta Schiliro; Martin Helan; Y S Prakash; David Linden; Christina Pabelick
Journal:  FASEB J       Date:  2020-08-10       Impact factor: 5.191

Review 10.  Animal models of bronchopulmonary dysplasia. The term mouse models.

Authors:  Jessica Berger; Vineet Bhandari
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-10-10       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.